Borderline Personality Disorder - 331-201-00242 (Otsuka)

Clinical trial to examine the efficacy and safety of brexpiprazole in patients with borderline personality disorder.

Qualified participants include:

  • Adults aged 18 to 65 years old
  • Have been diagnosed with borderline personality disorder

Those that qualify will:

  • Receive study drug and study-related care with a board-certified psychiatrist and other clinical staff at no cost. 
  • Receive reimbursement for study participation and costs.
  • Following the 12-week study, eligible/interested participants may choose to participate in an open-label extension study (331-201-00195, Otsuka).

Contact Ania Poltorak at 860-545-7265 or via email

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, please email
 or call 860.545.7476.

Click here to join